As such, future work could be improved by new strategies, such as quality control, that offer data regarding valve structure ... cardiac view. Quality enhancement techniques are essential in clinical ...

Abbott announced the US Food and Drug Administration (FDA) has approved the company's Tendyne transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease. This ...

The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement (TMVR) system for individuals with mitral valve disease. This device ...

For patients with severe MAC who are at high risk for open-heart surgery and whose mitral valve cannot be successfully repaired with the Abbott MitraClip™ device, Tendyne offers an alternative ...

The FDA has approved the company’s Tendyne system, as a minimally invasive heart replacement for patients with mitral valve disease that would otherwise make them ineligible for the top-selling ...

May 27, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR ...

My doctor ordered a series of heart scans that found slight mitral valve prolapse. What is that? Should I be worried? A Mitral valve prolapse is a condition that interferes with the one-way flow ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...

The condition is more common in women and younger patients with valve disorder and can, in the worst case, lead to sudden cardiac arrest. Mitral annular disjunction, MAD, is a heart abnormality in ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...